T

The University of Sydney | Save Sight Institute

Research site

(Unclaimed)

Location

8 Macquarie Street Level 1 South Block, Sydney, New South Wales, Australia

Site insights

Top conditions

Top treatments

Lampalizumab

APL-2

Aflibercept

ranibizumab

Bevacizumab

Latanoprost

Xalatan

Parent organization

This site is a part of The University of Sydney

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 13 total trials

Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration (i-SIGHT2)

The goal of this clinical trial is to characterize the safety and effectiveness of the i-Lumen AMD transpalpebral microcurrent device and therapy in...

Enrolling

Geographic Atrophy Secondary to Age-related Macular Degeneration

Intermediate AMD

Device: i-Lumen AMD

Trial sponsors

N

U

A

I

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms